138 related articles for article (PubMed ID: 15230045)
1. [Anti-ischemic effects of trimetazidine in patients with post-infarction heart failure].
Tepliakov AT; Sankevich qV; Stepacheva TA; Garganeeva AA; Filippov EA; Pushnikova EIu; Kaliuzhin VV; Efimova I; Zavadovskiĭ KV
Klin Med (Mosk); 2004; 82(5):57-62. PubMed ID: 15230045
[TBL] [Abstract][Full Text] [Related]
2. [Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease].
Fedorova TA; Il'ina IuV; Sotnikova TI; Rybakova MK
Klin Med (Mosk); 2004; 82(11):15-20. PubMed ID: 15656392
[TBL] [Abstract][Full Text] [Related]
3. [Decrease in the sensitivity to the anti-ischemic effect of propranolol and prospects for correcting it in patients with stable angina pectoris].
Butina EK; Kokurina EV; Dmitrieva NA; Bochkareva EV
Ter Arkh; 2002; 74(9):36-41. PubMed ID: 12418118
[TBL] [Abstract][Full Text] [Related]
4. [Clinical efficacy of combined therapy with enalapril + trimetazidine in patients with hypertension comorbid with ischemic heart disease and metabolic disturbances].
Petelina TI; Gapon LI; Bakhmatova IuA; Zhevagina IA
Ter Arkh; 2005; 77(8):19-23. PubMed ID: 16206600
[TBL] [Abstract][Full Text] [Related]
5. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure.
Fragasso G; Palloshi A; Puccetti P; Silipigni C; Rossodivita A; Pala M; Calori G; Alfieri O; Margonato A
J Am Coll Cardiol; 2006 Sep; 48(5):992-8. PubMed ID: 16949492
[TBL] [Abstract][Full Text] [Related]
6. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
Fragasso G; Perseghin G; De Cobelli F; Esposito A; Palloshi A; Lattuada G; Scifo P; Calori G; Del Maschio A; Margonato A
Eur Heart J; 2006 Apr; 27(8):942-8. PubMed ID: 16510466
[TBL] [Abstract][Full Text] [Related]
7. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
Di Napoli P; Di Giovanni P; Gaeta MA; Taccardi AA; Barsotti A
J Cardiovasc Pharmacol; 2007 Nov; 50(5):585-9. PubMed ID: 18030070
[TBL] [Abstract][Full Text] [Related]
8. [Effect of atenolol and trimetazidine on dispersion of cardiac rhythm in patients with moderately expressed postinfarction left ventricular dysfunction].
Kaliuzhin VV; Tepliakov AT; Kamaev DIu; Solovtsov MA
Ter Arkh; 2002; 74(8):42-4. PubMed ID: 12360593
[TBL] [Abstract][Full Text] [Related]
9. [Dilzem-retard efficiency in patients with ischemic heart disease and heart failure].
Gadzhiev AN
Klin Med (Mosk); 2002; 80(6):45-8. PubMed ID: 12138803
[TBL] [Abstract][Full Text] [Related]
10. [Trimetazidine effects on postinfarction remodeling of the left ventricle].
Kokov AN; Tarasov II; Barbarash LS
Ter Arkh; 2005; 77(8):10-4. PubMed ID: 16206598
[TBL] [Abstract][Full Text] [Related]
11. [Enhancement of antioxidant status of the elderly patients with ischemic heart disease in response to amino acid composition of MP-33 in combined therapy with trimetazidine].
Kalinina EB; Komissarova IA; Zaslavskaia RM; Zhdanov IuA
Klin Med (Mosk); 2002; 80(5):50-3. PubMed ID: 12087889
[TBL] [Abstract][Full Text] [Related]
12. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
Belardinelli R; Lacalaprice F; Faccenda E; Volpe L
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):533-40. PubMed ID: 18797405
[TBL] [Abstract][Full Text] [Related]
13. [The effects of trimetazidine on left ventricular function and physical exercise tolerance in patients with ischemic cardiomyopathy].
Sisakian AS; Torgomian AL; Barkhudarian AL
Klin Med (Mosk); 2006; 84(10):55-8. PubMed ID: 17201276
[TBL] [Abstract][Full Text] [Related]
14. Trimetazidine shortens QTc interval in patients with ischemic heart failure.
Zemljic G; Bunc M; Vrtovec B
J Cardiovasc Pharmacol Ther; 2010 Mar; 15(1):31-6. PubMed ID: 19966175
[TBL] [Abstract][Full Text] [Related]
15. Clinical benefits of trimetazidine in patients with recurrent angina.
Szwed H
Coron Artery Dis; 2004 May; 15 Suppl 1():S17-21. PubMed ID: 15179124
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathogenetic features of coronary heart disease combined with chronic obstructive pulmonary diseases and efficiency of therapy with trimetazidin].
Kolomoets NM; Baksheev VI; Uvaĭsova KU
Klin Med (Mosk); 2008; 86(6):38-43. PubMed ID: 18720710
[TBL] [Abstract][Full Text] [Related]
17. Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy.
Belardinelli R; Cianci G; Gigli M; Mazzanti M; Lacalaprice F
J Cardiovasc Pharmacol; 2008 Jun; 51(6):611-5. PubMed ID: 18574390
[TBL] [Abstract][Full Text] [Related]
18. [A role of activation of proinflammatory cytokines and production of autoimmune complexes in the pathogenesis of chronic heart failure in patients with postinfarct cardiac dysfunction].
Tepliakov AT; Debirov MM; Bolotskaia LA; Stepacheva TA; Rybal'chenko EV; Karaman NV
Klin Med (Mosk); 2004; 82(8):15-20. PubMed ID: 15468717
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic value of trimetazidine in patients with coronary heart disease and left ventricular dysfunction].
Multicentral Collaborative Group on Trimetazidine (Phase IV)
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Sep; 33(9):793-5. PubMed ID: 16266453
[TBL] [Abstract][Full Text] [Related]
20. Clinical benefits of a metabolic approach with trimetazidine in revascularized patients with angina.
Danchin N
Am J Cardiol; 2006 Sep; 98(5A):8J-13J. PubMed ID: 16931200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
